Skip to main content

Phase-3 trials find 1-shot chikungunya vaccine safe: Lancet

The first chikungunya vaccine may be on its way with phase 3 trials of a single-shot jab developed by French biotech company Valneva showing the vaccine to be generally safe, well tolerated and provoking an immune response. The study was conducted in the US. Its success will have significant implications for nations like India where chikungunya is endemic.

from Times of India https://ift.tt/63wiNdL
via
Labels:

Comments

Post a Comment

Popular posts from this blog

Kashmiri Pandit killed in J&K's Shopian, 7th since 2020

A terrorist shot dead 43-year-old Kashmiri Pandit farmer Puran Krishan Bhat outside his home in Choudharygund village of south Kashmir’s Shopian district Saturday morning, triggering protests in Jammu against the latest targeted attack on the community. DIG Sujit Kumar said Kashmir Freedom Fighter (KFF), the proxy name of a terrorist outfit, claimed responsibility for the attack on Bhat. from Times of India https://ift.tt/Sk9sv5q via
Post a Comment
Read more

Wet spell likely in north & central India till Jan 9: IMD

The India Meteorological Department (IMD) on Wednesday predicted a wet spell over northwest India, including Delhi-NCR, Punjab and Haryana, and central India till January 9 due to two consecutive active western disturbances. It, however, said that there may not be cold wave conditions over north India during the next five days. from Times of India https://ift.tt/34pJ29g via
Post a Comment
Read more